In the last decade, there have been significant advances in treating rheumatoid arthritis, especially for patients whose arthritis does not respond to traditional disease-modifying antirheumatic drugs (DMARDs). The most important advance has been the development of a group of drugs called biologic response modifiers or biologics.
There are a number of biologics approved to treat rheumatoid arthritis. These include:
Having RA must be difficult. Do people with arthritis have issues with holding objects like pencil, paper, and fork? If it is true they must have trouble with typing, using the computer, cell phone, smartphone, and touch screens.